Argenx
ARGX
#421
Rank
NZ$104.43 B
Marketcap
NZ$1,661
Share price
3.63%
Change (1 day)
7.42%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): NZ-$6.77

According to Argenx 's latest financial reports the company's current EPS (TTM) is NZ$40.05. In 2022 the company made an earnings per share (EPS) of NZ-$23.50.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$6.77-71.18%
2022NZ-$23.50